Home : Health : Novavax Vaccine – Development, Safety, And Usage For 12-17 Age Group

Novavax vaccine – Development, safety, and usage for 12-17 age group

Novavax vaccine – Development, safety, and usage for 12-17 age group

The Novavax COVID-19 vaccine, known as NVX-CoV2373, has gained prominence for its usefulness and safety. Originally authorized for adults aged 18 and over, it recently received FDA approval for emergency use in adolescents between 12 and 17. This vaccine defends against COVID-19 with an innovative protein-based technology. An expansion of usage means a broader age group can benefit from the protection, bolstering efforts to curb the pandemic’s spread and keep younger populations safe.

Additional approval from FDA
The FDA granted the Novavax COVID-19 emergency use authorization for adolescents aged 12 to 17, endorsing it as a two-dose primary series. Additionally, the CDC director issued a decision memo permitting the use of the Novavax COVID vaccine as a primary series choice for this adolescent group. The availability of a vaccine option designed using conventional protein-based technology is seen as a benefit. Experts believe the vaccination rates may rise, especially since children are back to school and socializing.

In related news, Novavax also worked on actively developing an updated version of its vaccine, tailored to target a specific variant of the virus and its offshoots. The company was looking forward to seeking authorization for this variant-targeting vaccine last year.

Development and safety of the vaccine
The development and safety of the Novavax COVID-19 vaccine for adolescents aged 12 to 17 have been carefully scrutinized and confirmed through comprehensive clinical trials. Novavax initially secured emergency use authorization for its vaccine in adults. Subsequently, the company conducted extensive research, including clinical trials involving adolescents, to assess the vaccine’s safety and efficacy within this age group.

The safety evaluation process of the Novavax vaccine in adolescents is meticulous. It involves monitoring potential side effects and adverse reactions. The data from these trials are subjected to rigorous analysis and scrutiny to ensure the vaccine meets stringent safety standards.

The expansion of the vaccine’s authorization to include adolescents reflects the confidence of regulatory agencies and healthcare authorities in its safety profile for this age group. This development underscores the commitment to providing a safe and valuable solution to protect younger individuals against COVID-19.

It’s essential to note that vaccine safety monitoring is an ongoing process even after authorization. This ensures any potential adverse events are promptly identified and assessed, contributing to the continuous improvement of vaccine safety.

The vaccine’s usefulness
Several factors play a crucial role in determining the effectiveness of a vaccine. Here are the critical factors in the case of Novavax:

  • Innovative technology
    Novavax’s vaccine relies on a novel approach known as protein subunit technology. It involves the creation of a nanoparticle that mimics the spike protein found on the surface of the SARS-CoV-2 virus, which causes COVID-19. This approach stimulates a robust immune response without using the live virus, making it safer.
  • Strong immune response
    The vaccine prompts the immune system to recognize and develop antibodies against the spike protein. In other words, if a vaccinated individual encounters the actual virus, their immune system is primed and ready to defend against it, reducing the risk of infection.
  • Efficacy
    Clinical trials have shown that the Novavax vaccine has a high level of effectiveness in preventing COVID-19. Studies have demonstrated an efficacy rate of around 90%, which means it could reduce the risk of illness among those who receive it.
  • Protection against variants
    The Novavax vaccine has shown to be useful against various SARS-CoV-2 variants, including some of the more concerning strains. This adaptability is crucial in a pandemic where the virus can change and produce new variants.
  • Favorable safety profile
    The vaccine has a favorable safety profile, with side effects generally being mild and transient, such as pain at the administration site, fatigue, or headache. These side effects are similar to those observed with other COVID-19 vaccines.
  • Accessible storage
    Novavax’s vaccine can be stored and transported at standard refrigerator temperatures, simplifying logistics and making it more accessible, especially in regions with limited cold storage infrastructure.

Different from other vaccines
The Novavax COVID-19 vaccine, NVX-CoV2373, distinguishes itself from other vaccines through its unique technology and characteristics:

  • Technology
    Novavax’s vaccine employs protein subunit technology. It utilizes a protein nanoparticle that mimics the spike protein of the SARS-CoV-2 virus, prompting an immune response. This differs from mRNA vaccines, which use genetic material to instruct cells to produce a part of the spike protein.
  • Traditional approach
    Unlike the mRNA vaccines that represent a newer approach to vaccination, Novavax’s technology is based on more traditional methods used in vaccine development. This may appeal to individuals who prefer vaccines with well-established track records.
  • Efficacy
    Novavax’s vaccine has demonstrated high efficacy, with clinical trials showing an effectiveness rate of approximately 90%. This is comparable to, or in some cases higher than, the efficacy rates of other authorized COVID-19 vaccines.
  • Storage and distribution
    A notable advantage of the Novavax vaccine is its ease of storage and distribution. It can be stored at standard refrigerator temperatures, simplifying logistics and making it suitable for regions with limited cold storage infrastructure.
  • Broad applicability
    Novavax’s vaccine has shown to be useful against various SARS-CoV-2 variants, including some of the more concerning strains. This adaptability is crucial in addressing the evolving landscape of the pandemic.
  • Global impact
    Novavax’s vaccine has the potential to make a significant global impact. Its accessibility and the fact that it can be produced in large quantities make it a valuable tool in the global effort to combat the virus and some of its variants.

Like all COVID-19 vaccines, breakthrough cases persist, where vaccinated individuals contract COVID-19. Experts emphasize that the virus’s transmission among vaccinated individuals will continue. However, the pivotal role of vaccines lies in diminishing hospitalizations and fatalities. The primary benefit is expected to manifest in alleviating the strain on healthcare facilities and ultimately safeguarding more lives over the long term.

Individuals should consult a professional healthcare provider for advice regarding vaccination and treatment. They can examine the patient and suggest the best solution for any health condition.

References :

1. https://www.ama-assn.org/delivering-care/public-health/fda-authorizes-novavax-vaccine-kids-ages-12-17-andrea-garcia-jd-mph

2. https://www.yalemedicine.org/news/novavax-covid-vaccine

3. https://www.aha.org/news/headline/2022-08-22-fda-expands-novavax-eua-include-children-12-and-older

4. https://www.who.int/news-room/feature-stories/detail/the-novavax-vaccine-against-covid-19-what-you-need-to-know

5. https://www.yalemedicine.org/news/covid-19-vaccine-comparison

Popular Reads

11 useful tips for anxiety management

11 useful tips for anxiety management

Nearly 84% of participants in a particular mental health survey were said to have some form of anxiety. The severity of symptoms did vary from person to person, but the fact remains that we live in a world where almost everything is a potential trigger for anxiety. And living in denial about having a psychological trigger only worsens the problem. Luckily, it is possible to manage anxiety by following the suggestions recommended by experts. Identify the triggers Anxiety is mainly triggered due to an event or episode where one finds themselves in a difficult position. It could be something that puts a person out of their comfort zone. Doctors advise people to identify these triggers and avoid them. Any comment, action, or situation that did not work out in favor triggers anxiety. So, make a list of such events and instances and ignore them the next time something happens related to that event. At the same time, try to remain positive as it can help strengthen the mind to manage anxiety better. Keep busy Distraction is one of the simplest ways to prevent a panic or anxiety attack. You can perform simple chores or indulge in a favorite task to stay physically and mentally occupied for a few hours. When the mind is occupied, there is hardly any scope for negative thoughts to trigger unnecessary overthinking. Some creative activities to boost cognitive performance include taking a walk, painting, drawing, listening to music, meditating, praying, and reading. You can opt for any of these to stay busy. Try mindfulness techniques Deep breathing and mindfulness techniques have helped thousands overcome their fear or anxiety time and again. Focused deep breathing is a method where one inhales for four counts and exhales for the same duration; this is practiced for minutes. It helps lower heart rate, which, in turn, calms the mind and body.
Atrial fibrillation – Causes, symptoms, and management tips

Atrial fibrillation – Causes, symptoms, and management tips

The human heart is susceptible to several health complications, including atrial fibrillation (AFib). The condition is the most common type of treated heart arrhythmia, which is a term describing when the heart beats unusually slowly, fast, or irregularly. AFib is estimated to affect between 2.7 million to 6.1 million individuals in the country. An individual with the complication experiences irregular beating in the heart’s upper chambers, affecting blood flow, leading to health complications. Causes Irregularities in the structure of the heart are the most common cause of atrial fibrillation. Sometimes people may develop the condition without any known heart damage or problems. Risk factors like age may also contribute to the development of atrial fibrillation. Other potential causes of the phenomenon include a heart attack, sick sinus syndrome – issues with the heart’s natural pacemaker, coronary artery disease, congenital heart defect – A heart defect that an individual might be born with, high blood pressure, lung diseases, heart valve problems, use of stimulants, including certain prescriptions and caffeine, physical stress caused due to pneumonia, other illnesses, and also surgery, sleep apnea, overactive thyroid (hyperthyroidism), metabolic imbalances, viral infections, and complications due to earlier heart surgery. Symptoms A person who develops atrial fibrillation may not notice symptoms, and the condition is detected only after a physical examination. But some people experience signs and symptoms before a diagnosis. A few common symptoms of AFib include being unable to exercise to one’s full potential, feelings of weakness, throbbing pain in the chest, lightheadedness, shortness of breath, dizziness, palpitations and sensations of a fast, fluttering, or pounding heartbeat, and feeling extremely fatigued. Therefore, the symptoms of atrial fibrillation differ from one person to the other. Occasional symptoms (paroxysmal atrial fibrillation) Here, a person may experience something that lasts from a few minutes to a couple of hours.
Macular degeneration – Types, causes, and remedies

Macular degeneration – Types, causes, and remedies

Macular degeneration is a condition that affects a person’s vision and develops as people age. This progressive eye disorder involves the deterioration of the macula, which is a part of the eye’s retina. It is a leading cause of vision loss in older adults and may develop in one or both eyes. This condition is of two main types – dry and wet. Read further to learn about the disorder, its causes, and its types. Dry macular degeneration People are more likely to have dry macular degeneration than wet form. It is also less severe and develops when tiny yellow protein deposits under the macula. These deposits dry and thin the macula, causing gradual central vision loss while the peripheral vision remains intact. In the advanced stages, the dry form can progress to the wet form. People with dry macular degeneration need to test their eyes daily at home using an Amsler grid. One must consult a health expert immediately if any vision changes are observed. Wet macular degeneration In this condition, the blood vessels grow beneath the retina and macula and cause blood and fluid to leak into the retina. This build-up of fluid results in scarring, leading to permanent loss of central vision. The wet form can cause a sudden change in eyesight resulting in a severe loss of centralized vision when left untreated. People with wet macular degeneration may require repeated treatments. Symptoms Macular degeneration may not cause any symptoms during the early stages. However, as the condition progresses, it can cause distortion and blurry vision. It can result in difficulty reading, driving, and identifying colors. Macular degeneration occurs mainly in people aged over 50. Blurred vision Dark, blurry areas appear in the center of the vision, leading to increased blurriness in reading printed words. Visual distortion The person may experience visual distortions, such as straight lines that look wavy or crooked, and objects may appear distorted.